258 related articles for article (PubMed ID: 33629860)
21. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic effect of ursodeoxycholic acid-berberine supramolecular nanoparticles on ulcerative colitis based on supramolecular system induced by weak bond].
Gao S; Gao F; Kong JW; Wang ZJ; Zheng HC; Jiang XQ; Xu SJ; Li SL; Lu MJ; Dai ZQ; Chu FH; Xu B; Lei HM
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2739-2748. PubMed ID: 37282934
[TBL] [Abstract][Full Text] [Related]
23. A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis.
Elvington M; Blichmann P; Qiao F; Scheiber M; Wadsworth C; Luzinov I; Lucero J; Vertegel A; Tomlinson S
Clin Exp Immunol; 2014 Aug; 177(2):500-8. PubMed ID: 24730624
[TBL] [Abstract][Full Text] [Related]
24. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis.
Chen S; Chen Z; Wang Y; Hao W; Yuan Q; Zhou H; Gao C; Wang Y; Wu X; Wang S
J Adv Res; 2022 Sep; 40():263-276. PubMed ID: 36100331
[TBL] [Abstract][Full Text] [Related]
25. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
[TBL] [Abstract][Full Text] [Related]
26. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.
Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M
Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381
[No Abstract] [Full Text] [Related]
27. Ramulus mori polysaccharide-loaded PLGA nanoparticles and their anti-inflammatory effects in vivo.
Feng Z; Peng S; Wu Z; Jiao L; Xu S; Wu Y; Liu Z; Hu Y; Liu J; Wu Y; Wang D
Int J Biol Macromol; 2021 Jul; 182():2024-2036. PubMed ID: 34087293
[TBL] [Abstract][Full Text] [Related]
28. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
29. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
30. Enhanced therapeutic effect of LK-423 in treating experimentally induced colitis in rats when administered in colon delivery microcapsules.
Smrdel P; Cerne M; Bogataj M; Urleb U; Mrhar A
J Microencapsul; 2010; 27(7):572-82. PubMed ID: 20690794
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.
Theiss AL; Laroui H; Obertone TS; Chowdhury I; Thompson WE; Merlin D; Sitaraman SV
Inflamm Bowel Dis; 2011 May; 17(5):1163-76. PubMed ID: 20872832
[TBL] [Abstract][Full Text] [Related]
32. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
33. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
34. Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.
Xu W; Su W; Xue Z; Pu F; Xie Z; Jin K; Polyakov NE; Dushkin AV; Su W
Pharm Res; 2021 Apr; 38(4):693-706. PubMed ID: 33754258
[TBL] [Abstract][Full Text] [Related]
35. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression.
Ahrari A; Najafzadehvarzi H; Taravati A; Tohidi F
Life Sci; 2021 Nov; 284():119884. PubMed ID: 34389401
[TBL] [Abstract][Full Text] [Related]
37. Eudragit
El-Maghawry E; Tadros MI; Elkheshen SA; Abd-Elbary A
Int J Nanomedicine; 2020; 15():3965-3980. PubMed ID: 32606658
[TBL] [Abstract][Full Text] [Related]
38. Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis.
Sun L; Nie X; Lu W; Zhang Q; Fang W; Gao S; Chen S; Hu R
AAPS PharmSciTech; 2022 Jun; 23(6):179. PubMed ID: 35761150
[TBL] [Abstract][Full Text] [Related]
39. Suppressive effect of berberine on experimental dextran sulfate sodium-induced colitis.
Hong T; Yang Z; Lv CF; Zhang Y
Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):391-7. PubMed ID: 22564173
[TBL] [Abstract][Full Text] [Related]
40. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
Li J; Yang L; Shen R; Gong L; Tian Z; Qiu H; Shi Z; Gao L; Sun H; Zhang G
J Nanobiotechnology; 2018 Oct; 16(1):76. PubMed ID: 30290822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
